share_log

Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea

Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea

Guardant Health 在韩国推出基于盾牌血液的结直肠癌筛查测试
Benzinga ·  2023/11/12 19:06

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

领先的精准肿瘤学公司Guardant Health, Inc.(纳斯达克股票代码:GH)宣布,它已与韩国三星医疗中心合作推出血液基结直肠癌筛查测试ShieldTM。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发